|
⚲
|
| Keyboard |
| Vicki Sato | |
|---|---|
| Firm | |
| Address | c/o Denali Therapeutics Inc 161 Oyster Point Blvd South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Denali Therapeutics Inc | 021-506551 | Director | 499.7 M of 499.7 M |
||
| VIR Biotechnology Inc | 021-366581 | Director | 32.4 M of 32.4 M |
||
| VIR Biotechnology Inc | 021-366580 | Director | 250.0 M of 250.0 M |
||
| Akouos Inc | 021-361803 | Director | 105.1 M of 105.1 M |
||
| VIR Biotechnology Inc | 021-315844 | Director | 66.0 M | ||
| Syros Pharmaceuticals Inc | 021-303459 | Director | 11.4 M of 11.4 M |
||
| Syros Pharmaceuticals Inc | 021-227114 | Director | 53.1 M of 53.1 M |
||
| Neurophage Pharmaceuticals Inc | 021-214921 | Director | 5.7 M of 17.1 M |
||
| Neurophage Pharmaceuticals Inc | 021-194074 | Director | 3.7 M of 8.3 M |
||
| Neurophage Pharmaceuticals Inc | 021-175217 | Director | 9.0 M of 9.0 M |
||
| Nimbus Discovery LLC | 021-156591 | Director | 1.5 M of 15.0 M |
||
| Neurophage Pharmaceuticals Inc | 021-156414 | Director | 8.4 M of 12.4 M |
||
| Nimbus Discovery LLC | 021-141296 | Director | 3.5 M of 3.5 M |
||
| Avila Therapeutics Inc | 021-117636 | Director | 22.5 M of 30.0 M |
||